ArticleInternal medicine (Tokyo, Japan)2025

Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with a Poor Performance Status.

Tsuyoshi Takeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.